HIP
ELV icon

Hatteras Investment Partners’s Elevance Health ELV Stock Holding History

Hatteras Investment Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,663
Closed -$1.34M – 116
2015
Q1 		$1.34M Buy
+8,663
New +$1.23M 0.72% 53

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Hatteras Investment Partners's ELV Position: Q2 2015 in Review

Hatteras Investment Partners sold out of Elevance Health (ELV) in Q2 2015, closing a stake of 8,663 shares — an estimated $1.34M sold.

Hatteras Investment Partners first reported a position in ELV in Q1 2015 and held it in 1 quarter. The position peaked at $1.34M in Q1 2015. 780 funds tracked by Wall St. Rank hold ELV as of Q2 2015.

  • Hatteras Investment Partners reported no remaining Elevance Health position as of Q2 2015 after selling out during the quarter.
  • Hatteras Investment Partners sold 8,663 Elevance Health shares in Q2 2015, an estimated $1.34M.
  • Hatteras Investment Partners first reported a position in Elevance Health in Q1 2015 and held it in 1 quarter.
  • Hatteras Investment Partners's Elevance Health position peaked at $1.34M in Q1 2015.
  • 780 funds tracked by Wall St. Rank held Elevance Health as of Q2 2015.

Based on Hatteras Investment Partners's 13F filing for Q2 2015, filed 13 Aug 2015.